Categories
Dialysis Tubing Set Correction: Vantive Updates Use Instructions for Prismaflex and Oxiris Sets
Prismaflex Set deaeration chambers may dislodge from the Prismaflex Control Unit during use.
Categories
Convenience Kit Needle Recall: Integra LifeSciences Removes Tuohy Needle
Integra LifeSciences is removing certain lots of Microsensor and Cerelink ICP Kits with potential corrosion stains on the included Tuohy Needle.
Categories
PAHO reports sustained yellow fever transmission in parts of South America
PAHO reports sustained yellow fever transmission in parts of South America
Oscar Reyes
13 Mar 2026
Categories
PAHO Director highlights regional commitment to eliminating leprosy at conference in Rio de Janeiro
PAHO Director highlights regional commitment to eliminating leprosy at conference in Rio de Janeiro
Cristina Mitchell
13 Mar 2026
Categories
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.
ACTON, Mass.–(BUSINESS WIRE)– Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”) today initiated a voluntary Medical Device Correction for specific lots of Omnipod® 5 Pods after identifying a manufacturing issue through its ongoing product monitoring. This action applies to specific i
Categories
FDA Launches New Adverse Event Look-Up Tool
FDA Launches New Adverse Event Look-Up Tool
http://www.fda.gov/news-events/press-announcements/fda-launches-new-adverse-event-look-tool
Categories
Nuevo informe de OPS destaca avances en el etiquetado frontal de alimentos en las Américas
New PAHO report highlights progress in front-of-package food labeling in the Americas
Cristina Mitchell
10 Mar 2026
Categories
FDA Approves First Treatment for Patients with Cerebral Folate Transport Deficiency
FDA Approves First Treatment for Patients with Cerebral Folate Transport Deficiency
http://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-patients-cerebral-folate-transport-deficiency
Categories
Early Alert: Flexible Cryoprobe Issue from Erbe USA
Erbe Cryoprobes may rupture during activation, leading to potential hearing loss, tinnitus, injury, or burns
Categories
FDA Takes Further Steps to Streamline Biosimilar Development and Make Medicines More Affordable
FDA Takes Further Steps to Streamline Biosimilar Development and Make Medicines More Affordable
http://www.fda.gov/news-events/press-announcements/fda-takes-further-steps-streamline-biosimilar-development-and-make-medicines-more-affordable
